ARRANGEMENT AGREEMENT BETWEEN TILRAY BRANDS, INC. AND HEXO CORP. APRIL 10, 2023Arrangement Agreement • April 13th, 2023 • HEXO Corp. • Medicinal chemicals & botanical products • Ontario
WHEREAS the Purchaser proposes to acquire all of the issued and outstanding Company Shares (as defined herein) pursuant to the Arrangement (as defined herein), as contemplated in this Agreement;
To: HEXO Corp. Ladies and Gentlemen: RE: Temporary Waiver and Amendment of Certain Covenants under the Amended and Restated Senior Secured Convertible Note due 2026HEXO Corp. • April 13th, 2023 • Medicinal chemicals & botanical products • Ontario
Reference is made to (i) that certain Amended and Restated Senior Secured Convertible Note due 2026 (the “HEXO Note”), dated as of July 12, 2022, issued by HEXO Corp. (“HEXO”) and held by Tilray Brands, Inc. (“Tilray”) and (ii) that certain Advisory Services Agreement (the “Services Agreement”), dated as of July 12, 2022, by and between Aphria Inc., a wholly-owned Subsidiary of Tilray, and HEXO. Any term used herein but not defined shall have the meaning ascribed to it in the HEXO Note.
FORM OF VOTING SUPPORT AGREEMENTVoting Support Agreement • April 13th, 2023 • HEXO Corp. • Medicinal chemicals & botanical products
THIS VOTING SUPPORT AGREEMENT (“Agreement”) is dated as of _______________, 2023, by and between Tilray Brands, Inc., a corporation existing under the laws of the State of Delaware (“Tilray”), and [●], an individual resident in the city of [●], [●] (the “Shareholder”).
